Great reading about the problems of on-the-ground use and reporting of off-label prescribing. You will need to see which camp your doctor falls into. I'm sure most doctors do not have time to write up research reports after they have given two patients the same off-label prescriptions. This means the knowledge may be out there but not being disseminated.
http://www.policymed.com/2013/10/despite-critics-dismissal-off-label-prescribing-may-benefit-patients.html?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+policymed+%28Policy+and+Medicine%29
This includes some reporting on amantadine which I have posted on here;
http://oc1dean.blogspot.com/2012/02/study-old-flu-drug-speeds-brain-injury.html
This basically proves that you will need to tell your doctor what you want done because they do not have the knowledge to know what to do. A great stroke association would be compiling all these off-label uses and assorted protocols for wider dissemination.
No comments:
Post a Comment